For healthcare institutions
A combination of different molecular techniques is key to reach clinical benefit
From molecular fingerprinting of the tumour to a personalised treatment strategy
What is the current situation in oncology practice?
We have developed solutions especially designed for your needs
Screening more than the usual suspects
We have developed a unique and powerful combination of biomarker tests to support your therapeutic decision-making: next-generation sequencing of large gene panels, immunohistochemistry analysis and other tests performed on both solid and/or liquid biopsies.
Clinical Decision Support Tools
From molecular complexity to clear decisions
OncoKDM is an online platform that turns your NGS data into actionable clinical information. Moreover, OncoKDM can integrate NGS results with IHC, MSI and TMB data. The resulting comprehensive and interactive report includes updated information about approved and investigational treatments for each patient, as well as NGS quality control data, patient clinical data and comprehensive NGS variants annotation.
Our platform OncoSHARE shows you the results of your patient’s molecular profiling through an online integrated theranostic report that includes a comprehensive biological and clinical interpretation. This report gives you an insight into the most effective treatments according to the unique features of your patient’s tumour, taking into account the most relevant scientific information, official cancer guidelines and recruiting clinical trials.